As of March 2024 Cytosorbents has a market cap of $50.48 Million. This makes Cytosorbents the world's 7744th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $50.48 M | -12.82% |
2023 | $57.91 M | -14.38% |
2022 | $67.63 M | -62.87% |
2021 | $0.18 B | -47.12% |
2020 | $0.34 B | 174.33% |
2019 | $0.12 B | -51.09% |
2018 | $0.25 B | 37.66% |
2017 | $0.18 B | 34.36% |
2016 | $0.13 B | -1.88% |
2015 | $0.14 B | -38.99% |
2014 | $0.23 B | 638.12% |
2013 | $31.41 M | 12.41% |
2012 | $27.94 M | -1.54% |
2011 | $28.38 M | 65.04% |
2010 | $17.19 M | 36.37% |
2009 | $12.61 M | 523.98% |
2008 | $2.02 M |
On Mar 27th, 2024 the market cap of Cytosorbents was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Boston Scientific BSX | $100.86 B | 199,680.74% | ๐บ๐ธ USA |
Hologic HOLX | $18.15 B | 35,862.32% | ๐บ๐ธ USA |
Meridian Bioscience VIVO | $1.48 B | 2,848.90% | ๐บ๐ธ USA |